1,452
Participants
Start Date
May 31, 2003
Primary Completion Date
September 30, 2005
Study Completion Date
September 30, 2005
SanOrg34006
LMW heparin
Unfractionated heparin
Vitamin K antagonist (VKA)
North Shore University Hospital, Manhasset
University of Rochester Medical Center, Rochester
Lehigh Valley Hospital, Allentown
Inova Alexandria Hospital, Alexandria
Pulmonary Associates, Fredericksburg
McGuire VAMC, Richmond
Medical College of Georgia, Augusta
Jackson Cardio-Vascular Clinic, Jacksonville
MIMA Century Research Associates, Melbourne
St. Joseph Mercy - Oakland Research Center, Pontiac
Health System Research Center, Grand Forks
Evanston Northwestern Healthcare, Evanston
Loyola University of Chicago, Maywood
Northwestern University, Chicago
Consultants in Pulmonary Medicine, Olathe
University of Oklahoma HSC, Oklahoma City
Scott and White Memorial Hospital & Clinic, Temple
James Muntz, Houston
University of Colorado Health Sciences Center, Denver
Lovelace Health Systems, Albuquerque
Swedish Medical Center, Seattle
William Dittman, Spokane
DeKalb Medical Center, Decatur
Boston Medical Center, Boston
Lead Sponsor
Sanofi
INDUSTRY